NEW USES OF Lp-PLA2 IN COMBINATION TO ASSESS CORONARY RISK
摘要
This invention relates to a method for assessing risk of Coronary Vascular Disease (CVD). Specifically, it relates to utilizing risk assessment from both Lipoprotein Associated Phospholipase A2 (Lp-PLA2) and C-reactive protein (CRP) in combination. In addition the invention relates to a method for assessing risk of Coronary Vascular Disease (CVD) in a patient with low to normal Low Density Lipoprotein Cholesterol (LDL) levels utilizing both LDL and Lipoprotein Associated Phospholipase A2 (Lp-PLA2). Moreover, the invention relates to the use of risk associated with Lp-PLA2, CRP and LDL in combination and specific ranges thereof to predict Coronary Vascular Disease.
申请公布号
WO2004089184(A2)
申请公布日期
2004.10.21
申请号
WO2004US10039
申请日期
2004.04.01
申请人
DIADEXUS, INC.;WOLFERT, ROBERT, L.;MAGUIRE, YU, PING;LI, YU, PING;SARNO, MARK, JOSEPH
发明人
WOLFERT, ROBERT, L.;MAGUIRE, YU, PING;LI, YU, PING;SARNO, MARK, JOSEPH